Rroji Merita, Spahia Nereida, Seferi Saimir, Barbullushi Myftar, Spasovski Goce
Department of Nephrology-Dialysis, UHC "Mother Teresa", Tirana, Albania.
University Department of Nephrology, Medical Faculty, University of Skopje, Skopje, Macedonia.
Ther Apher Dial. 2017 Oct;21(5):451-458. doi: 10.1111/1744-9987.12548. Epub 2017 Jul 17.
Atherosclerosis is frequently present in patients with chronic kidney disease (CKD) treated with dialysis. We evaluated the association between residual renal function (RRF), phosphate level, inflammation and other risk factors in carotid modeling as a marker of early atherosclerosis in peritoneal dialysis (PD) compared with hemodialysis (HD) patients. We studied 39 stable PD and 53 HD patients on renal replacement therapy (RRT) for 3 to 36 months duration. B-mode ultrasonography was used to determine carotid artery intima media thickness (CIMT). We classified patients with atherosclerosis if they have CIMT >10 mm and or presence of plaque. Out of our total dialysis population studied of 92 patients, 16.3% were diabetics and 57.6% were on hemodialysis. Expectedly, PD patients had a higher RRF (P < 0.001), 24 h urine volume (P < 0.001); C-reactive protein (P = 0.047), and a lower serum phosphate (P = 0.01), PTH (P < 0.05), alkaline phosphatase (P < 0.05), and albumin levels (P < 0.001) compared to hemodialysis patients. Atherosclerosis was found in 66.3% of patients and in 100% of a diabetic population. There was no significant difference in the presence of atherosclerosis between PD and HD patients [56.4 vs 73.6% HD, respectively]. Multiple regression analysis showed age, diabetes, HD modality, RRF, phosphate, PTH and pulse pressure as independent parameters associated with atherosclerosis. Apart from the traditional risk factors like age and diabetes, our study showed a link of atherosclerosis with metabolic abnormalities secondary to renal failure. We demonstrated a novel, independent association between RRF and atherosclerosis, underlining the importance of preservation of the RRF in dialysis patients.
接受透析治疗的慢性肾脏病(CKD)患者常伴有动脉粥样硬化。我们评估了残余肾功能(RRF)、血磷水平、炎症及其他危险因素与颈动脉形态之间的关联,颈动脉形态作为早期动脉粥样硬化的一个指标,用于比较腹膜透析(PD)和血液透析(HD)患者。我们研究了39例稳定的接受肾脏替代治疗(RRT)3至36个月的PD患者和53例HD患者。采用B型超声检查来测定颈动脉内膜中层厚度(CIMT)。若患者CIMT>10 mm和/或存在斑块,则将其归类为患有动脉粥样硬化。在我们研究的92例透析患者中,16.3%为糖尿病患者,57.6%接受血液透析。不出所料,与血液透析患者相比,PD患者的RRF更高(P<0.001)、24小时尿量更多(P<0.001)、C反应蛋白水平更高(P=0.047),而血清磷(P=0.01)、甲状旁腺激素(P<0.05)、碱性磷酸酶(P<0.05)和白蛋白水平更低(P<0.001)。66.3%的患者存在动脉粥样硬化,糖尿病患者中这一比例为100%。PD和HD患者之间动脉粥样硬化的发生率无显著差异[HD患者分别为73.6%和56.4%]。多元回归分析显示,年龄、糖尿病、HD方式、RRF、血磷、甲状旁腺激素和脉压是与动脉粥样硬化相关的独立参数。除了年龄和糖尿病等传统危险因素外,我们的研究表明动脉粥样硬化与肾衰竭继发的代谢异常有关。我们证实了RRF与动脉粥样硬化之间存在一种新的独立关联,强调了在透析患者中保留RRF的重要性。